SELLAS Life Sciences Group (SLS) Price Target Increased by 26.83% to $8.84

SELLAS Life Sciences Group's (SLS) average one-year price target has been revised to $8.84/share, an increase of 26.83% from the prior estimate of $6.97/share. The price target represents a 78.59% increase from the latest reported closing price of $4.95/share. There are 132 funds or institutions reporting positions in SLS, with Geode Capital Management holding 3.08M shares, and Millennium Management holding 1.39M shares.